Emerging role of the pentose phosphate pathway in hepatocellular carcinoma

Kowalik, Marta Anna
Writing - Original Draft Preparation
;
Columbano, Amedeo
Supervision
;
Perra, Andrea
Writing - Original Draft Preparation
2017-01-01

Abstract

In recent years, there has been a revival of interest in metabolic changes of cancer cells as it has been noticed that malignant transformation and metabolic reprogramming are closely intertwined. The pentose phosphate pathway (PPP) is one of the fundamental components of cellular metabolism crucial for cancer cells. This review will discuss recent findings regarding the involvement of PPP enzymes in several types of cancer, with a focus on hepatocellular carcinoma (HCC). We will pay considerable attention to the involvement of glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of the PPP. Subsequently, we discuss the inhibition of the PPP as a potential therapeutic strategy against cancer, in particular, HCC.
2017
Glucose-6-phosphate dehydrogenase; Hepatocellular carcinoma; Liver regeneration; Metabolic reprogramming; Pentose phosphate pathway; Preneoplastic lesions; Warburg metabolism; Oncology; Cancer Research
Files in This Item:
File Size Format  
fonc-07-00087.pdf

open access

Description: Articolo scientifico
Type: versione editoriale
Size 718.79 kB
Format Adobe PDF
718.79 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie